The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARγ. Influence of albumin

This publication has 36 references indexed in Scilit:

• Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease
  Prostaglandins & Other Lipid Mediators, 2003
• Celecoxib activates a novel mitochondrial apoptosis signaling pathway
  The FASEB Journal, 2003
• Selective cyclooxygenase‐2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells
  FEBS Letters, 2002
• Cox-2 Inhibitors: Today and Tomorrow
  The Lancet Healthy Longevity, 2002
• Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites
  British Journal of Pharmacology, 2002
• Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB
  The FASEB Journal, 2001
• The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2
  Journal of Biological Chemistry, 2000
• Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
  Nature Medicine, 1999
• Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
  Trends in Pharmacological Sciences, 1999
• Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
  Gastroenterology, 1999